Hubei Biocause Heilen Pharmaceutical Co., Ltd. (301211.SZ)

CNY 18.81

(0.16%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 2.54 Billion 2.49 Billion 2.33 Billion 803.24 Million 745.56 Million 640.23 Million
Total Current Assets 2.09 Billion 2.22 Billion 2.12 Billion 603.65 Million 575.43 Million 489.15 Million
Cash And Short Term Investments 1.82 Billion 1.96 Billion 1.85 Billion 345.26 Million 362.05 Million 61.62 Million
Cash and Cash Equivalents 1.69 Billion 1.85 Billion 1.85 Billion 105.26 Million 71.05 Million 61.62 Million
Short Term Investments 129.39 Million 103.97 Million - 240 Million 291 Million 64.99 Million
Net Receivables 89.15 Million 148.92 Million 173.03 Million 122.77 Million 138.07 Million 260.75 Million
Inventory 173.8 Million 114.7 Million 89.49 Million 134.59 Million 74.1 Million 96.13 Million
Other Current Assets 12.26 Million 1.2 Million 7.02 Million 1.02 Million 1.19 Million 70.63 Million
Total Non-Current Assets 447.62 Million 270.82 Million 201.13 Million 199.59 Million 170.12 Million 151.08 Million
Net PPE 361.99 Million 184.8 Million 131.7 Million 136.76 Million 126.91 Million 118.62 Million
Good Will And Intangible Assets 71.07 Million 73.27 Million 66.66 Million 61.44 Million 40.06 Million 31.98 Million
Good Will - - - - - -
Intangible Assets 71.07 Million 73.27 Million 66.66 Million 61.44 Million 40.06 Million 31.98 Million
Long-Term Investments 1.00 2.00 1.00 - - 2.00
Tax Assets 2.19 Million 1.27 Million 1.52 Million 1.38 Million 1.83 Million 221.87 Thousand
Other Non Current Assets 12.36 Million 11.46 Million 1.24 Million 1.00 1.31 Million 244.16 Thousand
Other Assets - - 1.00 - 1.00 -
Total Liabilities 187.78 Million 221.22 Million 107.52 Million 102.85 Million 257.31 Million 240.36 Million
Total Current Liabilities 175.14 Million 208.9 Million 103 Million 99.08 Million 252.94 Million 128.45 Million
Account Payables 109.79 Million 82.62 Million 36.12 Million 36.87 Million 40.33 Million 37.91 Million
Tax Payables 14.26 Million 20.42 Million 14.46 Million 23.97 Million 26.74 Million 14.75 Million
Short Term Debt 19.6 Million 965.61 Thousand 30.25 Million 7.25 Million 20 Million 6.5 Million
Deferred Revenue 15 Million 104.29 Million 6.34 Million 14.03 Million 159.7 Million 41.55 Million
Other Current Liabilities 30.73 Million 21.03 Million 30.27 Million 40.92 Million 32.9 Million 42.49 Million
Total Non Current Liabilities 12.64 Million 12.31 Million 4.52 Million 3.76 Million 4.37 Million 111.9 Million
Long-Term Debt 5.15 Million 6.43 Million 1.00 - - 110.5 Million
Deferred Revenue Non Current 2.09 Million 222.37 Thousand 280.38 Thousand 338.39 Thousand 396.4 Thousand 454.41 Thousand
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities -2.09 Million 1.00 - - - 1.00
Other Liabilities -0.00 - 1.00 1.00 - -
Total Equity 2.35 Billion 2.27 Billion 2.22 Billion 700.39 Million 488.24 Million 399.87 Million
Stock Holders Equity 2.35 Billion 2.27 Billion 2.22 Billion 700.39 Million 488.24 Million 286.09 Million
Common Stock 288 Million 240 Million 240 Million 180 Million 180 Million 180 Million
Retained Earnings 262.2 Million 198.43 Million 156.13 Million 46.17 Million 81.34 Million -18.94 Million
Accumulated other comprehensive income 49.97 Million 33.54 Million 22.12 Million 474.21 Million 226.9 Million 125.03 Million
Common Stock Equity 2.35 Billion 2.27 Billion 2.22 Billion 700.39 Million 488.24 Million 286.09 Million
Capital Lease Obligation 5.15 Million 6.43 Million - - - -
Total Investments 129.39 Million 103.97 Million 1.00 240 Million 291 Million 2.00
Total Debt 24.75 Million 7.39 Million 30.25 Million 7.25 Million 20 Million 117 Million
Net Debt -1.66 Billion -1.85 Billion -1.82 Billion -98 Million -51.05 Million 55.37 Million

Balance Sheet Charts